Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $354.24M.
ENTERPRISE VALUE (EV)
$354.24M
Viemed Healthcare, Inc.
Market Cap
$355.36M
Enterprise Value (EV)
$354.24M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Viemed Healthcare, Inc. (VMD) | $355.36M | $354.24M |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.82M | $376.06M |
| Turn Therapeutics Inc. (TTRX)vs › | $354.48M | $350.31M |
| Ocugen, Inc. (OCGN)vs › | $352.91M | $340.85M |
| Embecta Corp. (EMBC)vs › | $349.74M | $1.64B |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $359.28M | $67.67M |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $348.51M | $398.79M |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.88M | $318.63M |
| Opus Genetics, Inc. (IRD)vs › | $361.82M | $307.94M |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.02M | $332.68M |
Market Cap
$355.36M
Total Debt
$12.38M
Cash
$13.50M
Enterprise Value
$354.24M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
